Integrated Organ-on-a-chip with Human-induced Pluripotent Stem Cells Directional Differentiation for 3D Skin Model Generation

Zhang Luo , Chaihong Gong , Xiaowei Mao , Zhe Wang , Zhifan Liu , Yali Ben , Weiying Zhang

Journal of Wuhan University of Technology Materials Science Edition ›› 2023, Vol. 37 ›› Issue (6) : 1271 -1278.

PDF
Journal of Wuhan University of Technology Materials Science Edition ›› 2023, Vol. 37 ›› Issue (6) : 1271 -1278. DOI: 10.1007/s11595-022-2660-6
Biomaterials

Integrated Organ-on-a-chip with Human-induced Pluripotent Stem Cells Directional Differentiation for 3D Skin Model Generation

Author information +
History +
PDF

Abstract

Keratinocytes and fibroblasts, derived from hiPSCs, were used to construct the human epidermal model by a culture patch made by monolayer poly-(lactic-co-glycolic acid) (PLGA) nanofibers and a human skin-on-a-chip device. Unlike the conventional culture dish method, two different epidermal cells are successfully adhered to the front and back sides of the patch, which produces a three-dimensional nanofibrous scaffold similar to a natural extracellular matrix before the patch was cultured in the skin-on-a-chip device to mimic the physiological conditions of human skin. As expected, the differentiated hiPSCs show the expression of keratinocyte- and fibroblast- specific proteins on the patch, and the layering is found between these two kinds of cells, indicating that this approach creates a powerful in vitro system for modeling skin development and diseases.

Keywords

organ-on-a-chip / human-induced pluripotent stem cells / 3D skin model / direction differentiation

Cite this article

Download citation ▾
Zhang Luo, Chaihong Gong, Xiaowei Mao, Zhe Wang, Zhifan Liu, Yali Ben, Weiying Zhang. Integrated Organ-on-a-chip with Human-induced Pluripotent Stem Cells Directional Differentiation for 3D Skin Model Generation. Journal of Wuhan University of Technology Materials Science Edition, 2023, 37(6): 1271-1278 DOI:10.1007/s11595-022-2660-6

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Shevchenko RV, James SL, James SE. A Review of Tissue-engineered Skin Bioconstructs Available for Skin Reconstruction[J]. J. R. Soc. Interface., 2010, 7(43): 229-258.

[2]

Driskell RR, Lichtenberger BM, Hoste E, et al. Distinct Fibroblast Lineages Determine Dermal Architecture in Skin Development and Repair[J]. Nature., 2013, 504(7479): 277-281.

[3]

Lee VK, Dai G. Printing of Three-Dimensional Tissue Analogs for Regenerative Medicine[J]. Ann. Biomed. Eng., 2017, 45(1): 115-131.

[4]

Kim BS, Kwon YW, Kong JS, et al. 3D Cell Printing of Invitro Stabilized Skin Model and Invivo Pre-vascularized Skin Patch using Tissue-specific Extracellular Matrixbioink: A Step Yowards Advanced Skin Tissue Engineerings[J]. Biomaterials., 2018, 168: 38-53.

[5]

Mohammadi MH, Heidary-Araghi B, Beydaghi V, et al. Skin Diseases Modeling using Combined Tissue Engineering and Microfluidic Technologies[J]. Adv. Healthc. Mater., 2016, 5(19): 2 459-2 480.

[6]

Chen W, Han S, Qian W, et al. Nanotopography Regulates Motor Neuron Differentiation of Human Pluripotent Stem Cells[J]. Nanoscale., 2018, 10(7): 3 556-3 565.

[7]

Lee WH, Chen WY, Shao NY, et al. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell-versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes[J]. Stem Cells., 2017, 35(10): 2 138-2 149.

[8]

Adamiak M, Cheng G, Bobis-Wozowicz S, et al. Induced Pluripotent Stem Cell (iPSC)-Derived Extracellular Vesicles Are Safer and More Effective for Cardiac Repair than iPSCs[J]. Circ. Res., 2018, 122(10): 296-309.

[9]

Avior Y, Sagi I, Benvenisty N. Pluripotent Stem Cells in Disease Modelling and Drug Discovery[J]. Nat. Rev. Mol. Cell Biol., 2016, 17(3): 170-182.

[10]

Itoh M, Kiuru M, Cairo MS, et al. Generation of Keratinocytes from Normal and Recessive Dystrophic Epidermolysis Bullosa-induced Pluripotent Stem Cells[J]. P. Natl. Acad. Sci. USA., 2011, 108(21): 8 797-8 802.

[11]

Meng Y, Liu YL, Hou WX, et al. Mitomycin C-treated Human-induced Pluripotent Stem Cells as a Safe Delivery System of Gold Nanorods for Targeted Photothermal Therapy of Gastric Cancer[J]. Nanoscale., 2017, 9(1): 334-340.

[12]

Zhu YX, Liu TQ, Song KD, et al. Adipose Tissue-derived Stem Cell Expansion on Collagen/Chitosan Scaffolds in Bioreactor[J]. Cell Res., 2008, 18: S164.

[13]

Goulet CR, Bernard G, Chabaud S, et al. Tissue-engineered Human 3D Model of Bladder Cancer for Invasion Study and Drug Discovery[J]. Biomaterials, 2017, 145: 233-241.

[14]

Uhl CG, Muzykantov VR, Liu YL. Biomimetic Microfluidic Platform for the Quantification of Transient Endothelial Monolayer Permeability and Therapeutic Transport under Mimicked Cancerous Conditions[J]. Biomicrofluidics., 2018, 12(1): 014101

[15]

Rhee M, Valencia PM, Rodriguez MI, et al. Synthesis of Size-Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single-Layer Microchannels[J]. Adv. Mater., 2011, 23: H79-H83.

[16]

Zhang B, Montgomery M, Chamberlain MD, et al. Biodegradable Scaffold with Built-in Vasculature for Organ-on-a-chip Engineering and Direct Surgical Anastomosis[J]. Nat. Mater., 2016, 15(6): 669-678.

[17]

Kieninger J, Weltin A, Flamm H, et al. Microsensor Ssystems for Ccell Metabolism from 2D Culture to Organ-on-Chip[J]. Lab Chip., 2018, 18(9): 1 274-1 291.

[18]

Zheng FY, Fu FF, Cheng Y, et al. Organ-on-a-Chip Systems:Microengineering to Biomimic Living Systems[J]. Small., 2016, 12: 2 253-2 282.

[19]

Benam KH, Villenave R, Lucchesi C, et al. Small Airway-on-a-Chip Enables Analysis of Human Lung Inflammation and Drug Responses in Vitro[J]. Nat. Methods., 2016, 13(2): 151-157.

[20]

Jain A, Barrile R, Meer AVD, et al. Primary Human Lung Alveolus-on-a-Chip Model of Intravascular Thrombosis for Assessment of Therapeutics[J]. Clin. Pharmacol.Ther., 2018, 103(2): 332-340.

[21]

Bilousova G, Chen J, Roop DR. Differentiation of Mouse Induced Pluripotent Stem Cells into a Multipotent Keratinocyte Lineage[J]. J. Invest. Dermatol., 2011, 131(4): 857-864.

[22]

Bedel A, Taillepierre M, Guyonnet-Duperat V, et al. Metabolic Correction of Congenital Erythropoietic Porphyria with iPSCs Free of Reprogramming Factors[J]. Am. J. Hum. Genet., 2012, 91(1): 109-121.

[23]

Granovsky AE, Rosner MR. Raf Kinase Inhibitory Protein:a Signal Transduction Modulator and Metastasis Suppressor[J]. Cell Res., 2008, 18(4): 452-457.

[24]

Nemashkalo A, Ruzo A, Heemskerk I, et al. Morphogen and Community Effects Determine Cell Fates in Response to BMP4 Signaling in Human Embryonic Stem Cells[J]. Development (Cambridge, UK), 2017, 144(17): 3 042-3 053.

[25]

Itoh M, Umegaki-Arao N, Guo ZY, et al. Generation of 3D Skin Equivalents Fully Reconstituted from Human Induced Pluripotent Stem Cells(iPSCs)[J]. PLoS One., 2013, 8(10): e77673

[26]

Keller G. Embryonic Stem Cell Differentiation:Emergence of a New Era in Biology and Medicine[J]. Genes Dev., 2005, 19: 1 129-1 155.

[27]

Kurpinski K, Lam H, Chu J, et al. Transforming Growth Factor-β and Notch Signaling Mediate Stem Cell Differentiation into Smooth Muscle Cells[J]. Stem Cells, 2010, 28: 734-742.

[28]

Bagher Z, Azami M, Ebrahimi-Barough S, et al. Differentiation of Wharton’s Jelly-Derived Mesenchymal Stem Cells into Motor Neuron-Like Cells on Three-Dimensional Collagen-Grafted Nanofibers[J]. Mol. Neurobiol., 2016, 53(4): 2 397-2 408.

AI Summary AI Mindmap
PDF

108

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/